COYA Stock Analysis: Buy, Sell, or Hold?
COYA - Coya Therapeutics, Inc. Common Stock
$5.39
0.10 (1.89%)
▲
5d:
+10.22%
30d:
+11.36%
90d:
+27.73%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When COYA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: COYA is 7.6% above its trading range ($5.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: COYA is 7.6% above its trading range ($5.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: COYA is currently trading at $5.39, which is considered extended relative to its 30-day fair value range of $4.56 to $5.01.
Technical Outlook: Technically, COYA is showing sideways momentum. The price is approaching resistance at $5.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: COYA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.21 (+182.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, COYA is showing sideways momentum. The price is approaching resistance at $5.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: COYA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.21 (+182.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.56 -
$5.01
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range (+7.6% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 182.3% below Wall St target ($15.21)
- CAUTION: Extended 7.6% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$4.56 -
$5.01
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.51
(9.4%)
Support & Resistance Levels
Support Level
$4.30
Resistance Level
$5.21
Current Trend
Sideways
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.95
Wall Street Target
$15.21
(+182.3%)
Revenue Growth (YoY)
-2.6%
Profit Margin
-266.1%
Share & Embed Analysis
Last updated: June 24, 2026 9:14 AM ET
Data refreshes hourly during market hours. Next update: 10:14 AM
Data refreshes hourly during market hours. Next update: 10:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COYA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
